 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 April 1999 | Volume 130 Issue 7 | Pages 591-601
The autoimmune lymphoproliferative syndrome (ALPS) affords novel insights into the mechanisms that regulate lymphocyte homeostasis and underlie the development of autoimmunity. This syndrome arises early in childhood in persons who inherit mutations in genes that mediate apoptosis, or programmed cell death. The timely deletion of lymphocytes is a way to prevent their accumulation and the persistence of cells that can react against the body's own antigens. In ALPS, defective lymphocyte apoptosis permits chronic, nonmalignant adenopathy and splenomegaly; the survival of normally uncommon "double-negative" CD3+ CD4 –CD8 –T cells; and the development of autoimmune disease. Most cases of ALPS involve heterozygous mutations in the lymphocyte surface protein Fas that impair a major apoptotic pathway. Detailed immunologic investigations of the cellular and cytokine profiles in ALPS show a prominent skewing toward a T-helper 2 phenotype; this provides a rational explanation for the humoral autoimmunity typical of patients with ALPS. Prospective evaluations of 26 patients and their families show an ever-expanding spectrum of ALPS and its major complications: hypersplenism, autoimmune hemolytic anemia, thrombocytopenia, and neutropenia. Defective apoptosis may also contribute to a heightened risk for lymphoma.
Author and Article Information
For definitions of terms used in the text, see Glossary.
An edited summary of a Clinical Staff Conference held on 25 February 1998 at the National Institutes of Health, Bethesda, Maryland.
Authors who wish to cite a section of the conference and specifically indicate its author may use this example for the form of the reference: Lenardo MJ. Molecular regulation of lymphocyte apoptosis, pp 595-596. In: Straus SE, moderator. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med. 1999; 130:591-601.
Requests for Reprints: Stephen E. Straus, MD, Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, Building 10, Room 11N228, 10 Center Drive, National Institutes of Health, Bethesda, MD 20892-1888; e-mail, sstraus{at}nih.gov.
Current Author Addresses: Drs. Straus and Strober: Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, Building 10, Room 11N228, 10 Center Drive, National Institutes of Health, Bethesda, MD 20892-1888.
Dr. Lenardo: Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, Building 10, Room 11N331, 10 Center Drive, National Institutes of Health, Bethesda, MD 20892.
Dr. Puck: Immunologic Genetics Branch, National Human Genome Research Institute, Building 49, Room 3W14, 9000 Rockville Pike, National Institutes of Health, Bethesda, MD 20892.
Dr. Sneller: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Building 10, Room 11C410, 10 Center Drive, National Institutes of Health, Bethesda, MD 20892. NIH CONFERENCE
An Inherited Disorder of Lymphocyte Apoptosis: The Autoimmune Lymphoproliferative Syndrome
This article has been cited by other articles:
|
|
 |
|
  E. Orilieri, G. Cappellano, R. Clementi, A. Cometa, M. Ferretti, E. Cerutti, F. Cadario, M. Martinetti, D. Larizza, V. Calcaterra, et al. Variations of the Perforin Gene in Patients With Type 1 Diabetes Diabetes, April 1, 2008; 57(4): 1078 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Teachey, A. E. Seif, V. I. Brown, M. Bruno, R. M. Bunte, Y. J. Chang, J. K. Choi, J. D. Fish, J. Hall, G. S. Reid, et al. Targeting Notch signaling in autoimmune and lymphoproliferative disease Blood, January 15, 2008; 111(2): 705 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Farley, D. E. Purdy, O. P. Ryabinina, P. Schneider, B. E. Magun, and M. S. Iordanov Fas Ligand-induced Proinflammatory Transcriptional Responses in Reconstructed Human Epidermis: RECRUITMENT OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND ACTIVATION OF MAP KINASES J. Biol. Chem., January 11, 2008; 283(2): 919 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Vinay, J. D. Kim, T. Asai, B. K. Choi, and B. S. Kwon Absence of 4 1BB Gene Function Exacerbates Lacrimal Gland Inflammation in Autoimmune-Prone MRL-Faslpr Mice Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4608 - 4615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Illes, H. Waldner, J. Reddy, A. C. Anderson, R. A. Sobel, and V. K. Kuchroo Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background Int. Immunol., October 1, 2007; 19(10): 1235 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Singh, M. Nagarkatti, and P. S. Nagarkatti Role of Dioxin Response Element and Nuclear Factor-{kappa}B Motifs in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Regulation of Fas and Fas Ligand Expression Mol. Pharmacol., January 1, 2007; 71(1): 145 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Clementi, A. Chiocchetti, G. Cappellano, E. Cerutti, M. Ferretti, E. Orilieri, I. Dianzani, M. Ferrarini, M. Bregni, C. Danesino, et al. Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function Blood, November 1, 2006; 108(9): 3079 - 3084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Huston Update in allergy and immunology. Ann Intern Med, September 19, 2006; 145(6): 454 - 458. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Woelfel, J. Bixby, M. A. Brehm, and F. K.-M. Chan Transgenic Expression of the Viral FLIP MC159 Causes lpr/gld-Like Lymphoproliferation and Autoimmunity J. Immunol., September 15, 2006; 177(6): 3814 - 3820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Teachey, D. A. Obzut, K. Axsom, J. K. Choi, K. C. Goldsmith, J. Hall, J. Hulitt, C. S. Manno, J. M. Maris, N. Rhodin, et al. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS) Blood, September 15, 2006; 108(6): 1965 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Fortner and R. C. Budd The Death Receptor Fas (CD95/APO-1) Mediates the Deletion of T Lymphocytes Undergoing Homeostatic Proliferation J. Immunol., October 1, 2005; 175(7): 4374 - 4382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Salmena and R. Hakem Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder J. Exp. Med., September 19, 2005; 202(6): 727 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Cowley, E. Hamilton, J. A. Frelinger, J. Su, J. Forman, and K. L. Elkins CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo J. Exp. Med., July 18, 2005; 202(2): 309 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Teachey, C. S. Manno, K. M. Axsom, T. Andrews, J. K. Choi, B. H. Greenbaum, J. M. McMann, K. E. Sullivan, S. F. Travis, and S. A. Grupp Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS) Blood, March 15, 2005; 105(6): 2443 - 2448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chiocchetti, M. Indelicato, T. Bensi, R. Mesturini, M. Giordano, S. Sametti, L. Castelli, F. Bottarel, M. C. Mazzarino, L. Garbarini, et al. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation Blood, February 15, 2004; 103(4): 1376 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wu, M. A. McKenna, X. Feng, T. R. Nagy, and J. M. McDonald Osteoclast Apoptosis: The Role of Fas in Vivo and in Vitro Endocrinology, December 1, 2003; 144(12): 5545 - 5555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Greil, G. Anether, K. Johrer, and I. Tinhofer Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools J. Leukoc. Biol., September 1, 2003; 74(3): 311 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Bomprezzi, P E Kovanen, and R Martin New approaches to investigating heterogeneity in complex traits J. Med. Genet., August 1, 2003; 40(8): 553 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Salmena, B. Lemmers, A. Hakem, E. Matysiak-Zablocki, K. Murakami, P.Y. B. Au, D. M. Berry, L. Tamblyn, A. Shehabeldin, E. Migon, et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity Genes & Dev., April 1, 2003; 17(7): 883 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Holler, A. Tardivel, M. Kovacsovics-Bankowski, S. Hertig, O. Gaide, F. Martinon, A. Tinel, D. Deperthes, S. Calderara, T. Schulthess, et al. Two Adjacent Trimeric Fas Ligands Are Required for Fas Signaling and Formation of a Death-Inducing Signaling Complex Mol. Cell. Biol., February 15, 2003; 23(4): 1428 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Davidson, C. Haudenschild, J. Kwon, and M. S. Williams T Cell Receptor Ligation Triggers Novel Nonapoptotic Cell Death Pathways That Are Fas-Independent or Fas-Dependent J. Immunol., December 1, 2002; 169(11): 6218 - 6230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Balaji, N. Schaschke, W. Machleidt, M. Catalfamo, and P. A. Henkart Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation J. Exp. Med., August 19, 2002; 196(4): 493 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Watanabe, K. Ikuta, S. Nisitani, T. Chiba, and T. Honjo Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice J. Exp. Med., July 1, 2002; 196(1): 141 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. van den Berg, E. Maggio, A. Diepstra, D. de Jong, J. van Krieken, and S. Poppema Germline FAS gene mutation in a case of ALPS and NLP Hodgkin lymphoma Blood, February 15, 2002; 99(4): 1492 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. H. Bleesing, M. R. Brown, S. E. Straus, J. K. Dale, R. M. Siegel, M. Johnson, M. J. Lenardo, J. M. Puck, and T. A. Fleisher Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome Blood, October 15, 2001; 98(8): 2466 - 2473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Baud, O. Goulet, D. Canioni, F. Le Deist, I. Radford, D. Rieu, S. Dupuis-Girod, N. Cerf-Bensussan, M. Cavazzana-Calvo, N. Brousse, et al. Treatment of the Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome (IPEX) by Allogeneic Bone Marrow Transplantation N. Engl. J. Med., June 7, 2001; 344(23): 1758 - 1762. [Full Text] [PDF]
|
|
|
|
|
|
U. Lopatin, X. Yao, R. K. Williams, J. J. H. Bleesing, J. K. Dale, D. Wong, J. Teruya-Feldstein, S. Fritz, M. R. Morrow, I. Fuss, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression Blood, May 15, 2001; 97(10): 3161 - 3170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sallah, J. Y. Wan, and L. R. Hanrahan Future Development of Lymphoproliferative Disorders in Patients with Autoimmune Hemolytic Anemia Clin. Cancer Res., April 1, 2001; 7(4): 791 - 794. [Abstract] [Full Text]
|
|
|
|
|
|
S. DeFranco, S. Bonissoni, F. Cerutti, G. Bona, F. Bottarel, F. Cadario, A. Brusco, G. Loffredo, I. Rabbone, A. Corrias, et al. Defective Function of Fas in Patients With Type 1 Diabetes Associated With Other Autoimmune Diseases Diabetes, March 1, 2001; 50(3): 483 - 488. [Abstract] [Full Text]
|
|
|
|
|
|
D. A. Jabs, B. Lee, J. Whittum-Hudson, and R. A. Prendergast The Role of Fas-Fas Ligand-Mediated Apoptosis in Autoimmune Lacrimal Gland Disease in MRL/MpJ Mice Invest. Ophthalmol. Vis. Sci., February 1, 2001; 42(2): 399 - 401. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Y. Chang and X. Yang Proteases for Cell Suicide: Functions and Regulation of Caspases Microbiol. Mol. Biol. Rev., December 1, 2000; 64(4): 821 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Comi, M. Leone, S. Bonissoni, S. DeFranco, F. Bottarel, C. Mezzatesta, A. Chiocchetti, F. Perla, F. Monaco, and U. Dianzani Defective T cell Fas function in patients with multiple sclerosis Neurology, October 10, 2000; 55(7): 921 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zuklys, G. Balciunaite, A. Agarwal, E. Fasler-Kan, E. Palmer, and G. A. Hollander Normal Thymic Architecture and Negative Selection Are Associated with Aire Expression, the Gene Defective in the Autoimmune-Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) J. Immunol., August 15, 2000; 165(4): 1976 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Siegel, J. K. Frederiksen, D. A. Zacharias, F. K.-M. Chan, M. Johnson, D. Lynch, R. Y. Tsien, and M. J. Lenardo Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations Science, June 30, 2000; 288(5475): 2354 - 2357. [Abstract] [Full Text]
|
|
|
|
|
|
U. Ramenghi, S. Bonissoni, G. Migliaretti, S. DeFranco, F. Bottarel, C. Gambaruto, D. DiFranco, R. Priori, F. Conti, I. Dianzani, et al. Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer Blood, May 15, 2000; 95(10): 3176 - 3182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Griffin, D. K. Hong, P. O. Holman, K.-M. Lee, M. J. Whitters, S. M. O'Herrin, F. Fallarino, M. Collins, D. M. Segal, T. F. Gajewski, et al. Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152) J. Immunol., May 1, 2000; 164(9): 4433 - 4442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Gronbaek, T. Dalby, J. Zeuthen, E. Ralfkiaer, and P. Guldberg The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism in the Danish population Blood, March 15, 2000; 95(6): 2184 - 2185. [Full Text] [PDF]
|
|
|
|
|
|
D. A. Jabs, B. Lee, J. A. Whittum–Hudson, and R. A. Prendergast Th1 Versus Th2 Immune Responses in Autoimmune Lacrimal Gland Disease in MRL/Mp Mice Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 826 - 831. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. J. Pinkoski, T. Brunner, D. R. Green, and T. Lin Fas and Fas ligand in gut and liver Am J Physiol Gastrointest Liver Physiol, March 1, 2000; 278(3): G354 - G366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Israels and E. D. Israels Apoptosis Stem Cells, September 1, 1999; 17(5): 306 - 313. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. G. Israels and E. D. Israels Apoptosis Oncologist, August 1, 1999; 4(4): 332 - 339. [Abstract] [Full Text]
|
|
Article
